Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural stem cells as potential mediators of prenatal dietary stress through epigenetic mechanisms.

Stem cell reports·2026
Same author

Association between blood mitochondrial DNA copy number and cognitive function: A cross-sectional study based on the Yakumo Study.

Fujita medical journal·2026
Same author

Do epigenetic aging biomarkers mediate the association between exposure and health outcomes? A scoping review of mediation analysis.

Environmental research·2026
Same author

An Exploratory Prospective Intervention Study on Dietary Content and HbA1c in Experiential Nutrition Guidance for Patients with Type 2 Diabetes.

Nutrients·2026
Same author

Induction of oxidative stress-associated cell death in HepG2 cells by combined methylmercury and palmitic acid exposure at low non-toxic concentrations.

Bioscience, biotechnology, and biochemistry·2026
Same author

Effects of High-Protein Nutritional Guidance on Sarcopenia-Related Parameters in Individuals Aged ≥ 75 Years with Type 2 Diabetes: An Exploratory Single-Arm Pre-Post Intervention Study.

Nutrients·2025

Related Experiment Video

Updated: May 3, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K

Circulating microRNAs in autoimmune thyroid diseases.

Hiroya Yamada1, Mitsuyasu Itoh, Izumi Hiratsuka

  • 1Department of Hygiene, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Clinical Endocrinology
|February 19, 2014
PubMed
Summary
This summary is machine-generated.

Circulating microRNAs (miRNAs) show distinct levels in autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's thyroiditis (HT). These findings suggest miRNAs may contribute to the pathogenesis of AITDs.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: May 3, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.8K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Area of Science:

  • Endocrinology
  • Immunology
  • Molecular Biology

Background:

  • Autoimmune thyroid diseases (AITDs), such as Graves' disease (GD) and Hashimoto's thyroiditis (HT), are prevalent autoimmune conditions.
  • MicroRNAs (miRNAs) are critical regulators of immune function and autoimmunity development.
  • Circulating miRNAs offer potential biomarkers for disease pathogenesis and clinical status in autoimmune disorders.

Purpose of the Study:

  • To investigate and characterize the distinct circulating levels of microRNAs (miRNAs) in patients diagnosed with autoimmune thyroid diseases (AITDs).

Main Methods:

  • Serum samples were collected from 64 participants, including patients with HT or GD and healthy controls.
  • Microarray analysis was employed to identify differential miRNA expression patterns in serum.
  • Quantitative real-time PCR was used to validate the expression levels of selected miRNAs (miR-16, miR-22, miR-375, and miR-451).

Main Results:

  • Microarray analysis revealed differential expression of several miRNAs in the serum of AITD patients compared to healthy individuals.
  • Serum levels of miR-22, miR-375, and miR-451 were significantly elevated in patients with Hashimoto's thyroiditis (HT).
  • Serum levels of miR-16, miR-22, miR-375, and miR-451 were found to be increased in patients with Graves' disease (GD).

Conclusions:

  • Distinct serum microRNA profiles are associated with Graves' disease (GD) and Hashimoto's thyroiditis (HT).
  • These identified circulating miRNAs may play a significant role in the underlying pathogenesis of autoimmune thyroid diseases (AITDs).